| GC46319-50mg |
|
— |
(1R,3S)-3-Hydroxycyclopentane acetic acid methyl ester
|
0 |
C8H14O3 |
|
|
|
| GC46318-50mg |
|
— |
(1R,3S)-3-Hydroxycyclopentane acetic acid
|
0 |
C7H12O3 |
|
|
|
| GC46317-250mg |
|
1110772-05-8 |
(1R,3S)-3-Amino-cyclopentanol
|
0 |
C5H11NO |
|
|
|
| GC46317-100mg |
|
1110772-05-8 |
(1R,3S)-3-Amino-cyclopentanol
|
0 |
C5H11NO |
|
|
|
| GC46317-50mg |
|
1110772-05-8 |
(1R,3S)-3-Amino-cyclopentanol
|
0 |
C5H11NO |
|
|
|
| GC46317-10mg |
|
1110772-05-8 |
(1R,3S)-3-Amino-cyclopentanol
|
0 |
C5H11NO |
|
|
|
| GC46316-50mg |
|
— |
(1R,3R)-3-Hydroxycyclopentane acetic acid methyl ester
|
0 |
C8H14O3 |
|
|
|
| GC46315-50mg |
|
— |
(1R,3R)-3-Benzoic acid 3-carboxycyclopentyl ester
|
0 |
C13H14O4 |
|
|
|
| GC46314-10mg |
|
1219804-68-8 |
(±)-β-Hydroxybutyrate-d4 (sodium salt)
|
0 |
C4H3D4O3.Na |
|
|
|
| GC46314-5mg |
|
1219804-68-8 |
(±)-β-Hydroxybutyrate-d4 (sodium salt)
|
0 |
C4H3D4O3.Na |
|
|
|
| GC46314-1mg |
|
1219804-68-8 |
(±)-β-Hydroxybutyrate-d4 (sodium salt)
|
0 |
C4H3D4O3.Na |
|
|
|
| GC46313-1mg |
|
— |
(±)-α-Tocopherol Acetate-d3
|
0 |
C31H49D3O3 |
|
|
|
| GC46313-500μg |
|
— |
(±)-α-Tocopherol Acetate-d3
|
0 |
C31H49D3O3 |
|
|
|
| GC46312-5mg |
|
— |
(±)-Verapamil-d3 (hydrochloride)
|
0 |
C27H35D3N2O4.HCl |
|
|
|
| GC46312-1mg |
|
— |
(±)-Verapamil-d3 (hydrochloride)
|
0 |
C27H35D3N2O4.HCl |
|
|
|
| GC46312-500μg |
|
— |
(±)-Verapamil-d3 (hydrochloride)
|
0 |
C27H35D3N2O4.HCl |
|
|
|
| GC46309-5mg |
|
— |
(±)-threo-4-Fluoroethylphenidate (hydrochloride)
|
0 |
C15H20FNO2.HCl |
|
|
|
| GC46309-1mg |
|
— |
(±)-threo-4-Fluoroethylphenidate (hydrochloride)
|
0 |
C15H20FNO2.HCl |
|
|
|
| GC46308-1mg |
|
— |
(±)-Sitagliptin-d4 (hydrochloride)
|
0 |
C16H11D4F6N5O.HCl |
|
|
|
| GC46308-500μg |
|
— |
(±)-Sitagliptin-d4 (hydrochloride)
|
0 |
C16H11D4F6N5O.HCl |
|
|
|
